tiprankstipranks
Trending News
More News >
Advertisement
Advertisement
Milestone Pharmaceuticals’ Cardamyst NDA Resubmission Boosts Buy Rating Amid FDA Progress
PremiumRatingsMilestone Pharmaceuticals’ Cardamyst NDA Resubmission Boosts Buy Rating Amid FDA Progress
3M ago
Milestone Pharmaceuticals Announces Public Offering for $48.7M
Premium
Company Announcements
Milestone Pharmaceuticals Announces Public Offering for $48.7M
3M ago
Why Is Milestone Pharmaceuticals Stock (MIST) Down 30% Today?
Premium
Market News
Why Is Milestone Pharmaceuticals Stock (MIST) Down 30% Today?
3M ago
Milestone announces FDA acceptance of response to CARDAMYST CRL
PremiumThe FlyMilestone announces FDA acceptance of response to CARDAMYST CRL
3M ago
Milestone Pharmaceuticals’ Cardamyst Resubmission Boosts Buy Rating Amid Positive FDA Feedback and Market Potential
Premium
Ratings
Milestone Pharmaceuticals’ Cardamyst Resubmission Boosts Buy Rating Amid Positive FDA Feedback and Market Potential
4M ago
Milestone Pharmaceuticals Submits Response to FDA for CARDAMYST
Premium
Company Announcements
Milestone Pharmaceuticals Submits Response to FDA for CARDAMYST
4M ago
Milestone Pharmaceuticals Reports Q1 2025 Financial Results
PremiumCompany AnnouncementsMilestone Pharmaceuticals Reports Q1 2025 Financial Results
5M ago
Milestone Pharmaceuticals Navigates Regulatory Challenges and Financial Updates in Q1 2025
Premium
Company Announcements
Milestone Pharmaceuticals Navigates Regulatory Challenges and Financial Updates in Q1 2025
5M ago
Milestone Pharmaceuticals reports Q1 EPS (31c) vs (21c) last year
Premium
The Fly
Milestone Pharmaceuticals reports Q1 EPS (31c) vs (21c) last year
5M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100